Thursday, December 5, 2013 at Online
Starts at 2:00 PM · Ends at 3:00 PM, EDT (America/New_York)
Join Dr. Pam Spencer from Dow Chemical Co. to learn how integrating toxicology assessments at an early stage in product development can be better for the environment and your bottom line. This presentation will explore the benefits and challenges of conducting alternative assessments. Strategies, tools and guidance will also be discussed.
What You Will Learn
- Key criteria and data important in assessing chemical/product alternatives
- How to match data needs to product development stage
- Strategies for managing data gaps (guidance, tools)
- Emerging needs/areas for future research
- And much more…
Date: Thursday, December 5, 2013
Time: 2:00-3:00 pm ET
Meet Your Experts
Pam Spencer is the Product Sustainability Consulting Director for the Toxicology, Environmental, Research and Consulting (TERC) Group at Dow. She has worked for Dow for 27years. She leads the TERC Sustainable Chemistry Team and co-chairs the HESI Alternatives Assessment Subcommittee. She completed a PhD in toxicology at University of Michigan and is a Diplomat of the American Board of Toxicology.
Dr. Joseph Fortunak is an organic chemist. He spent 21 years in the pharmaceutical industry, most recently as head of global chemical development at Abbott Labs. Dr. Fortunak is a professor at Howard University, specializing in green chemistry and global access to medicines. He works with organizations including the WHO, UNITAID, the Clinton Foundation, and the Kilimanjaro School of Pharmacy.